12/23
07:00 am
icu
SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial
Medium
Report
SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial
12/16
09:00 pm
icu
SEASTAR ALERT: Bragar Eagel & Squire, P.C. is Investigating SeaStar Medical Holding Corp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Medium
Report
SEASTAR ALERT: Bragar Eagel & Squire, P.C. is Investigating SeaStar Medical Holding Corp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
12/11
06:30 am
icu
SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications
High
Report
SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications
12/4
08:30 am
icu
SeaStar Medical to Hold Business Update Conference Call on December 11, 2024
Low
Report
SeaStar Medical to Hold Business Update Conference Call on December 11, 2024
12/3
08:30 am
icu
SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial
Low
Report
SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial
11/26
08:00 am
icu
SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024
Low
Report
SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024
11/22
08:30 am
icu
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical’s Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares
High
Report
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical’s Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares
11/15
08:30 am
icu
SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer
Medium
Report
SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer
11/13
05:05 pm
icu
SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update
High
Report
SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update
11/6
09:00 am
icu
FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis
High
Report
FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis
11/1
08:30 am
icu
Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial
High
Report
Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial
10/31
08:30 am
icu
SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE
High
Report
SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE
10/25
11:32 am
icu
Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update
Low
Report
Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update
10/25
08:30 am
icu
Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024
High
Report
Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024
10/23
08:30 am
icu
SeaStar Medical Announces that Stanford Medicine is Cleared to Actively Enroll Subjects in the Adult Acute Kidney Injury Pivotal Trial
High
Report
SeaStar Medical Announces that Stanford Medicine is Cleared to Actively Enroll Subjects in the Adult Acute Kidney Injury Pivotal Trial
10/22
08:30 am
icu
SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers
Low
Report
SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers
10/18
08:30 am
icu
SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis
Medium
Report
SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis
10/15
08:30 am
icu
SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week
Low
Report
SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week
10/9
08:30 am
icu
SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit
Low
Report
SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit
10/8
08:30 am
icu
SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities
Low
Report
SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities
9/25
08:30 am
icu
SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial
High
Report
SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial